IL6 and neoplasm: In PDAC patients, the elevated IL-6 levels found in serum, pancreatic juice and tissue, appear to predict tumor stage and survival, thus supporting the potential role of this cytokine as a malignancy predictor, but its sensitivity and specificity are extremely variable [59].